ViraferonPeg (peginterferon-α-2b) / Merck (MSD)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ViraferonPeg (peginterferon-α-2b) / Merck (MSD)
ChiCTR-TRC-09000638: A Study on the viral kinetics of different regimes of Pegylated Interferon and Lamivudine combination therapy in HBeAg Positive Chronic Heptatitis B

Completed
N/A
30
 
PEG-Intron A 100mcq sc once weekly, Lamivudine 100mg QD treatment period 104 weeks (include 32 doses of PEG-Intron A and 96 or 104 weeks Lamivudine) versus one year treatment of Lamivudine 100mg QD
Schering-Plough; None, Hepatitis Research Fund
Viral Diseases
 
 

Download Options